| 我国临床前药物致癌试验转基因动物模型研究进展 |
| |
| 引用本文： | 杨艳伟,刘甦苏,吕建军,王三龙,张素才,柳全明,范昌发.我国临床前药物致癌试验转基因动物模型研究进展[J].中国药事,2019,33(8):880-886. |
| |
| 作者姓名： | 杨艳伟 刘甦苏 吕建军 王三龙 张素才 柳全明 范昌发 |
| |
| 作者单位： | 中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院实验动物资源研究所, 北京 102609,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,北京昭衍新药研究中心股份有限公司, 北京 100176,中国食品药品检定研究院实验动物资源研究所, 北京 102609,中国食品药品检定研究院实验动物资源研究所, 北京 102609 |
| |
| 摘 要： | 目的：综述我国临床前药物致癌试验转基因动物模型研究进展。方法：介绍致癌试验常用转基因动物模型的构建、利用转基因动物模型开展致癌试验的优势、国际认可及国际监管机构新药申报中的应用、国内外致癌试验相关指导原则、我国开展基于转基因动物致癌试验面临的困境以及转基因动物模型构建的最新进展。结果与结论：基于转基因动物模型的致癌试验具有诸多优势也是目前国际趋势，在我国建立临床前药物致癌试验转基因动物模型非常必要。
|
| 关 键 词： | 临床前 药物 致癌试验 转基因动物模型 研究进展 |
| 收稿时间： | 2019/7/10 0:00:00 |
Research Progress of Transgenic Animal Models for Preclinical Carcinogenicity Study of Drugs in China |
| |
| Yang Yanwei,Liu Susu,Lv Jianjun,Wang Sanlong,Zhang Sucai,Liu Quanming and Fan Changfa.Research Progress of Transgenic Animal Models for Preclinical Carcinogenicity Study of Drugs in China[J].Chinese Pharmaceutical Affairs,2019,33(8):880-886. |
| |
| Authors: | Yang Yanwei Liu Susu Lv Jianjun Wang Sanlong Zhang Sucai Liu Quanming and Fan Changfa |
| |
| Institution: | Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102609, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,JOINN Laboratories(China) Co., Ltd., Beijing 100176, China,Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102609, China and Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102609, China |
| |
| Abstract: | Objective:To introduce the research progress of transgenic animal models for preclinical carcinogenicity study of drugs in China. Methods:The establishment of commonly used transgenic animal models for preclinical carcinogenicity study of drugs, advantages of the carcinogenicity study using transgenic animal models, international recognition and new drug application submitted to international regulatory agencies, guidelines for carcinogenicity study at home and abroad, dilemma of carrying out carcinogenicity study based on transgenic animal models in China, as well as latest progress of establishing transgenic animal models for carcinogenicity study in China were introduced. Results and Conclusion:The carcinogenicity study based on the transgenic animal models has many advantages and is now an global trend. It is necessary to establish transgenic animal models for preclinical carcinogenicity study of drugs in China. |
| |
| Keywords: | preclinical drug carcinogenicity study transgenic animal model research progress |
|
| 点击此处可从《中国药事》浏览原始摘要信息 |
| 点击此处可从《中国药事》下载免费的PDF全文 |
|
